In Conversation: Trip Hofer

In a sector where hype routinely outruns delivery, it is worth listening closely to Trip Hofer, CEO, Redox. In a wide-ranging conversation conducted by MedCity News, Trip laid out a view of the industry that is both candid and immediately useful to the executives, clinicians, and builders who read HealthTech Cube.

The conversation

How the interoperability company is adapting to TEFCA and the QHIN ecosystem, securing data exchange, and its cloud partnership plans.

“We think of QHINs as another way to connect.”
- Trip Hofer, in conversation with MedCity News

Conversation highlights

The bigger picture

The data-infrastructure backdrop makes this conversation timely: TEFCA crossed one billion exchanged health records this summer, up from 10 million in under a year (our coverage), while KLAS reports EHR purchasing fell 40% as capital shifts from record systems to the AI and analytics layered on top of them. Interoperability is no longer the constraint - deciding what to do with flowing data is.

Virtual care's policy clock frames everything: Medicare telehealth flexibilities run through December 31, 2027, hospital-at-home through 2030, and utilization jumped 10.1% in Q1 2026 alone (our coverage). Health systems making the moves discussed here are building against that runway - and lobbying to make it permanent.

What makes the discussion valuable is its refusal to stay abstract: every point lands on a real workflow, budget, or patient. At Redox, that thinking translates into daily decisions about where technology genuinely earns its place in care delivery, and where discipline matters more than novelty.

The HTC take

The through-line matches what our reporting keeps finding across the industry: adoption succeeds where governance, workflow, and evidence move together.